Aviva PLC Boosts Stake in Healthpeak Properties, Inc. $DOC

Aviva PLC boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 6.6% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 593,721 shares of the real estate investment trust’s stock after acquiring an additional 36,603 shares during the quarter. Aviva PLC’s holdings in Healthpeak Properties were worth $10,396,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after purchasing an additional 7,872,150 shares in the last quarter. Nuveen LLC purchased a new stake in Healthpeak Properties in the first quarter valued at approximately $124,113,000. Invesco Ltd. lifted its position in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. Nordea Investment Management AB grew its stake in Healthpeak Properties by 7,444.0% in the 2nd quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after buying an additional 3,871,201 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Healthpeak Properties by 57.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after buying an additional 2,477,307 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DOC. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a report on Wednesday, August 27th. Scotiabank lowered Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and dropped their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Cantor Fitzgerald initiated coverage on Healthpeak Properties in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a report on Wednesday, October 8th. Finally, Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the stock an “outperform” rating in a research note on Wednesday, July 30th. Seven equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $20.91.

Read Our Latest Research Report on Healthpeak Properties

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $17.91 on Wednesday. The company has a market capitalization of $12.45 billion, a P/E ratio of -358.13, a PEG ratio of 3.84 and a beta of 1.10. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $22.71. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.28 and a current ratio of 1.22. The stock has a 50 day moving average price of $18.38 and a two-hundred day moving average price of $17.84.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping the consensus estimate of $0.45 by $0.01. The company had revenue of $705.87 million for the quarter, compared to the consensus estimate of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.8%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s payout ratio is currently -2,440.00%.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Read More

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.